Free Trial

Five9 (FIVN) Competitors

Five9 logo
$42.63 +1.15 (+2.77%)
(As of 12/20/2024 05:16 PM ET)

FIVN vs. WPP, ALLE, CART, MEDP, ULS, GLOB, STN, HQY, MARA, and BILI

Should you be buying Five9 stock or one of its competitors? The main competitors of Five9 include WPP (WPP), Allegion (ALLE), Maplebear (CART), Medpace (MEDP), UL Solutions (ULS), Globant (GLOB), Stantec (STN), HealthEquity (HQY), MARA (MARA), and Bilibili (BILI). These companies are all part of the "business services" industry.

Five9 vs.

WPP (NYSE:WPP) and Five9 (NASDAQ:FIVN) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation, dividends and community ranking.

Five9 received 267 more outperform votes than WPP when rated by MarketBeat users. Likewise, 68.93% of users gave Five9 an outperform vote while only 55.06% of users gave WPP an outperform vote.

CompanyUnderperformOutperform
WPPOutperform Votes
332
55.06%
Underperform Votes
271
44.94%
Five9Outperform Votes
599
68.93%
Underperform Votes
270
31.07%

Five9 has a consensus target price of $58.18, indicating a potential upside of 36.47%. Given Five9's stronger consensus rating and higher probable upside, analysts plainly believe Five9 is more favorable than WPP.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WPP
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Five9
0 Sell rating(s)
5 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.72

4.3% of WPP shares are owned by institutional investors. Comparatively, 96.6% of Five9 shares are owned by institutional investors. 1.0% of WPP shares are owned by insiders. Comparatively, 1.8% of Five9 shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

WPP has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Five9 has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.

In the previous week, Five9 had 51 more articles in the media than WPP. MarketBeat recorded 52 mentions for Five9 and 1 mentions for WPP. WPP's average media sentiment score of 0.44 beat Five9's score of 0.20 indicating that WPP is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WPP
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Five9
9 Very Positive mention(s)
8 Positive mention(s)
29 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

WPP has higher revenue and earnings than Five9. Five9 is trading at a lower price-to-earnings ratio than WPP, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WPP$14.85B0.80$137.33M$5.888.89
Five9$1.00B3.20-$81.76M-$0.50-85.26

WPP has a net margin of 0.00% compared to Five9's net margin of -3.66%. WPP's return on equity of 0.00% beat Five9's return on equity.

Company Net Margins Return on Equity Return on Assets
WPPN/A N/A N/A
Five9 -3.66%-1.53%-0.44%

Summary

WPP beats Five9 on 10 of the 19 factors compared between the two stocks.

Get Five9 News Delivered to You Automatically

Sign up to receive the latest news and ratings for FIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FIVN vs. The Competition

MetricFive9Data processing & preparation IndustryComputer SectorNASDAQ Exchange
Market Cap$3.21B$4.34B$25.83B$9.08B
Dividend YieldN/A2.86%2.77%4.22%
P/E Ratio-85.2632.97237.9417.18
Price / Sales3.201,743.093,330.10116.79
Price / Cash59.5833.4735.8537.86
Price / Book5.766.128.094.78
Net Income-$81.76M$44.01M$681.16M$225.60M
7 Day Performance1.00%-3.80%0.43%-1.23%
1 Month Performance10.18%5.18%6.99%3.36%
1 Year Performance-46.25%15.86%23.04%16.59%

Five9 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FIVN
Five9
4.1982 of 5 stars
$42.63
+2.8%
$58.18
+36.5%
-44.7%$3.21B$1.00B-85.262,684Analyst Forecast
Options Volume
WPP
WPP
2.335 of 5 stars
$55.68
-0.5%
N/A+10.4%$12.64B$14.85B9.52114,732
ALLE
Allegion
4.2275 of 5 stars
$138.83
flat
$144.60
+4.2%
+9.7%$12.07B$3.65B21.3312,400Ex-Dividend
Positive News
CART
Maplebear
4.233 of 5 stars
$42.62
+2.0%
$47.14
+10.6%
+81.5%$10.95B$3.04B28.563,380Insider Trade
Positive News
MEDP
Medpace
4.6869 of 5 stars
$348.25
+0.7%
$380.56
+9.3%
+11.3%$10.82B$1.89B30.295,900
ULS
UL Solutions
2.0105 of 5 stars
$51.42
+1.1%
$49.00
-4.7%
N/A$10.29B$2.68B0.0015,233
GLOB
Globant
4.0489 of 5 stars
$219.76
+1.4%
$229.00
+4.2%
-5.0%$9.47B$2.35B56.9529,150Analyst Forecast
STN
Stantec
3.6875 of 5 stars
$82.23
-0.5%
N/A+3.5%$9.38B$4.80B37.5528,000Positive News
HQY
HealthEquity
3.2938 of 5 stars
$93.11
-2.6%
$110.71
+18.9%
+47.1%$8.07B$1.15B87.723,150Positive News
MARA
MARA
3.6635 of 5 stars
$24.92
+9.6%
$24.56
-1.5%
-9.7%$8.02B$387.51M31.159Analyst Forecast
Insider Trade
Analyst Revision
Gap Down
BILI
Bilibili
2.1656 of 5 stars
$19.29
-2.6%
$19.69
+2.1%
+78.1%$7.99B$3.19B-20.958,801

Related Companies and Tools


This page (NASDAQ:FIVN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners